Plaque Modification Removal Devices Market Report: Market Size & Forecast 2026

Plaque modification and removal devices are specialized medical instruments used in catheter-based procedures to treat arterial blockages caused by atherosclerosis. The market includes atherectomy devices, thrombectomy devices, and other plaque-modifying technologies employed in both coronary and peripheral vascular interventions. According to industry analysis, the global market was valued at approximately $3.62 billion in 2025 and is expected to expand steadily through 2034, with different research firms projecting values between $6.7 billion and higher figures by the early 2030s.

• •The atherectomy segment, a key component of plaque removal, was valued at approximately $866 million to $1.03 billion in 2025
• •The broader peripheral vascular devices market, which includes plaque modification as a segment, was estimated at $14.73 billion with a 5.2% CAGR forecast through 2029
• •No government statistical agency publishes specific market size metrics for this device category; figures are compiled from industry and company data sources

The primary force behind market expansion is the growing global burden of cardiovascular diseases, particularly peripheral artery disease and coronary artery disease, which increase demand for interventional procedures. Technological advancements have improved device efficacy and safety, encouraging wider adoption among healthcare providers. Additionally, the trend toward minimally invasive surgical alternatives over traditional open procedures has significantly boosted demand for catheter-based plaque modification technologies.

• •Rising prevalence of lifestyle-related conditions such as diabetes, obesity, and hypertension contributes to higher rates of atherosclerosis
• •An aging global population correlates with increased incidence of vascular diseases requiring interventional treatment
• •Growing preference for minimally invasive procedures reduces hospital stays and recovery times, driving physician and patient adoption

The market is segmented by device type, including atherectomy devices, thrombectomy devices, and other plaque modification systems, as well as by end user and geography. North America currently leads the market due to advanced healthcare infrastructure, high procedural volumes, and favorable reimbursement policies. The Asia-Pacific region is expected to exhibit the fastest growth, driven by improving healthcare access, rising disease prevalence, and increasing medical tourism.

• •Atherectomy devices represent a significant sub-segment, with projections ranging from $866 million to over $1 billion in 2025 depending on scope
• •Europe and North America collectively account for the largest market share, while emerging markets in Asia-Pacific and Latin America show accelerating adoption
• •The peripheral vascular applications segment benefits from approximately 200 million people worldwide affected by peripheral artery disease

What are the recent trends and outlook?

Several emerging trends are shaping the future trajectory of the plaque modification devices market, including the development of drug-coated balloons and combination therapies designed to reduce restenosis rates. Integration of imaging guidance with atherectomy procedures is gaining traction as clinicians seek to optimize plaque removal accuracy. The market is also seeing increased focus on outpatient and ambulatory surgical center settings, which may expand addressable patient populations and influence device pricing strategies.

• •Hybrid procedures combining multiple plaque modification techniques are becoming more common as treatment protocols evolve
• •Technological innovation is moving toward directional atherectomy and orbital atherectomy systems with enhanced lesion-crossing capabilities
• •The market's projected CAGR of approximately 7.16% through 2034 reflects sustained demand outpacing many other medical device segments